Categories
Connect with us on LinkedIn
From Paper to eCOA / ePRO: Bringing flexibility & efficiency to your clinical trials
In this on demand webinar discover if your protocol is a good candidate for eCOA / ePRO, and...
Accelerating AI Innovation in Pharma: Collaboration versus Competition
Should clinical trial companies collaborate to speed up innovation in AI, or is a healthy dose of competition...
How Optina Diagnostics uses Castor EDC in research of earlier disease detection
Learn how partnering with Castor helped Optina to save time and money, and to gain FDA clearance for...
Castor collaborates with Microsoft to bring Practical AI to clinical trials.
Today, Castor announces its collaboration with Microsoft to integrate Practical AI in clinical trials, reducing trial burdens for...
eConsent Readiness Guide in 24 Countries
eConsent regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 24 countries...
Kicking-off 2024: A year of optimism & opportunity
Listen in for Derk’s take on the JPM conference, and what to expect from a first quarter filled...
2023: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
Creating Real World Evidence: Researching the impact of medical AI on a global scale
Castor’s clinical trial platform supports Ada Health’s research goals with patient-friendly surveys, easy-to-build eCRFs, and a flexible, compliant...
The AI Hype and Reality: Key Highlights from CNS Summit 2023
At this year's CNS Summit, Castor achieved a remarkable feat by winning the AI Demo Awards. Watch more...
10 FAQs on eConsent
To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address...
What to expect at the CNS Summit Live AI Demo
As the world works towards a future of AI-assisted solutions, we believe that everyone who is involved in...
Product Spotlight: Dive deep into Castor’s eConsent
This product spotlight webinar will help you gain a deeper understanding of Castor’s eConsent capabilities for patients, sponsors...
Don’t Overengineer It: Hybrid Designs Overcome Barriers in DTx Clinical Trials
At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials
Understand Barriers to eConsent Adoption from Site and Sponsor Perspectives
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
A Digital-First Mindset Shift on eConsent
eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical...
Navigating successful eConsent adoption from sponsor to site
Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent...
Preparing for Post-Market Clinical Follow-Up Under EU MDR
Download our White Paper: Preparing for Post-Market Clinical Follow-up (PMCF) under EU MDR (European Union Medical Device Regulation)...
Harnessing the power of Patient-centric Technologies
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
Connect with us on LinkedIn
